We have vaccines to boost our immune response to SARS-CoV-2, the virus that causes COVID. We have medicines you can take at home (and in hospital) to treat COVID. Now researchers are trialing something new.
Nov 28, 2022
0
20
After sun exposure, people with systemic lupus erythematosus (SLE) frequently develop skin rashes, which often are accompanied by a flare of their overall disease. This connection between ultraviolet (UV) light and disease ...
Nov 13, 2022
0
2
Bowel cancers can be grouped into six clinically meaningful subtypes based on patterns of gene interactions commonly seen within tumor cells, according to research published today in eLife.
Nov 8, 2022
0
8
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether ...
Nov 8, 2022
0
0
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
A new model for understanding which patients with sepsis, COVID-19 and influenza have immune dysfunction and are more likely to suffer poor outcomes has been developed by researchers at the Wellcome Sanger Institute, the ...
Nov 2, 2022
0
35
Researchers from the Epigenetics and Immune Disease Lab at the Josep Carreras Leukaemia Research Institute have recently shown that vitamin C improves the immunogenic properties of dendritic cells in vitro.
Nov 2, 2022
0
5
Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.
Nov 1, 2022
2
181
A clinical trial evaluating two different immunization schedules for a new COVID-19 vaccine shows that both regimens generate a similar immune response, according to results published today in eLife.
Oct 25, 2022
0
16
World Health Organization chief Tedros Adhanom Ghebreyesus said Wednesday that clinical trials could start within weeks on vaccines to combat the strain of Ebola behind a deadly outbreak in Uganda.
Oct 12, 2022
0
11
